A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mamatha, T.
- Evaluation of Medication Errors in an Acute Multi Care Unit in a Tertiary Care Hospital
Authors
1 Department of Pharmacology, Sultan-ul-Uloom College of Pharmacy, Mount Peasant, 8-2-249, Road No. 3, Banjara Hills, Hyderabad - 34, Telangana, IN
Source
Journal of Pharmaceutical Research, Vol 15, No 3 (2016), Pagination: 86-90Abstract
Purpose of the study : The aim of the study was to evaluate medication errors in the Acute Multi Care Unit in a tertiary care hospital. The study aims to promote safety in medication use and ensure quality in the healthcare service. The study objective was to detect and categorize medication errors, to ensure rational drug use in the hospital, to make recommendations for doctors, nurses, and patients to promote safe use of medications.
Design and Methodology : The study was conducted in 152 inpatients in the Acute Multi Care Unit in a tertiary care hospital located in Hyderabad. It is a prospective observational study carried over a period of 8 months. Data was collected using a data collection form which included patient details, drug details, and criteria for identifying errors, its categorization, and the details of drugs involved in errors. Complete details of patients and medications were recorded through a review of nursing charts, patient's admission chart, patient's history sheet and doctor's order sheet. Collected details were then evaluated to detect the prescribing, administration, omission error, dose error and poly pharmacy.
Results: The study was conducted in 152 patients, where total number of prescriptions with error is 28. The percentage distribution of prescriptions with error (18%) and without error (82%) was also calculated. Among which prescribing errors (50%) were the most frequently occurring types of errors, which was followed by omission errors (18%), administration error (18%) and dose error (14%). Error prescriptions belonging to male patients were (60.7%) while for females it was (39.3%). And a total of 26 Poly pharmacy prescriptions were also reported among which (69%) belongs to male and (31%) belongs to female.
Conclusion: The professionals involved in the practice should be focused, alert and determined. The nursing staff also needs to be slightly more knowledgeable and focused. Since this is an observational study and there is no scope of any intervention which can modify outcome.
Keywords
Medication Error, Acute Multi Care Unit, Polypharmacy, Prescribing Error, Administration Error, Omission Error and Dose Error.Full Text
References
- Marc G. Nursing error and human nature. Journal of Nursing Law.2004;9:37–44.
- Cheraghi MA, Nikbakhat Nasabadi AR, Mohammad Nejad E, Salari A, Ehsani Kouhi Kheyli SR. Medication Errors Among Nurses in Intensive Care Units (ICU). Journal of Mazandaran University Medical Sciences. 2012;22(1):115–9.
- Hashemi F. Response ethics to nursing errors. Journal of Medical Ethics and History of Medicine. 2007; 4: 31–46.
- Johnstone MJ, Kanitsaki O. The ethics and practical importance of defining, Distinguishing and discloring errors: A discussion paper. International Journal of Nursing Studies.2006;43:367–76.
- Wood A, Doan-Johnson S. Executive summaey: Toward-toxonomy of nursing practice errors. Journal of Nursing Management.2002;33:45–8.
- Mohammadnejad E, Hojjati H, Sharifnia SH, Ehsani SR. Amount and type of medication errors in nursing students in four Tehran. Journal of Medical Ethics and History of Medicine.2009;3(1):60–9.
- Mihailidis A, Krones L, Boger J. Assistive computing devices:A pilot study to explore nurses preference and needs. Computers Informatics Nursing. 2006; 24: 328–36.
- Mrayyon MT, Shishani K, Al-faouri L. Rate, causes and reporting of medication errors in Jordan: Nurses' perspectives. Journal of Nursing Management. 2007;15:659–70.
- Armitage G, Knapman H. Adverse events in drug administration: A literature review Journal of Nursing Management.2003;11:130–40.
- Tang FI, Sheu SJ, Yu S, Wei IL, Chen CH. Nurses relate the contributing factors involved in medication errors. Journal of Clinical Nursing.2007;16:447–55.
- Ates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. Journal of General Internal Medicine.1995;10:199–205.
- Mason DJ.To forgive, divine: It is time to drop the veil of secrecy about dislosing errors. American Journal of Nursing.2005;105:11-16.
- Carlton G, Blegen MA. Medication-related errors: A literature review of incidence and antecedents. Annual Review of Nursing Research.2006;24:19–38.
- Kessler JZ Medication Errors. Linda Y. Fred, Manual for Pharmacy Technicians, 3rd edition, American Society of Health-System Pharmacists.2013;325-355.
- The National Coordinating Council for Medication Error Reporting and Prevention. Defining the Problem and Developing Solutions 2005. www.nccmerp.org/sites/ default/files/ fifteen_year_report.pdf
- Bobb A, Kristine G, Marla H, Joe F, Paul RY. 2004 the Epidemiology of Prescribing Errors, the Potential Impact of Computerized Prescriber Order Entry. Achieves of Internal Medicine Journal. 2004; 164(7): 785-92.
- Schachter M. The Epidemiology of Medication Errors: How Many, How Serious? British Journal of Clinical Pharmacology.2009;67:621-623.
- Rixt Nynke Eggink, Albert W. Lenderink, Jos W. M. G. Widdershoven, Patricia M. L. A. van den Bemt.. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharmacy World and Science.2010;32:759–766.
- Vd B, Idzinga J, Robertz H, Kormelink D, Pels N. Medication administration errors in nursing homes using an automated medication dispensing system. Journal of the American Medical Informatics Association.2009;16(4):486–492.
- Benkirane R, Abougual R, Haimeur C, SS SECEK, Azzouzi A, Mdaghri AA, Thimou A, Nejmi M, Maazouzi W, Madani N, et al. Incidence of adverse drug events and medication adminstration errors in intensive care units.Journal of Patient Safety.2009;5(1):16–22.
- Tissot E, Cornette, Demoly P, Jaquet M. Medication errors at the administration stage in an intensive care unit.Intensive care medicin.1999;25:353-359.
- Slabaugh S. L, Maio V., Templin M., Abouzaid S. "Prevalence and risk of polypharmacy among the elderly in an outpatient setting: A retrospective cohort study in the Emilia Romagna region, Italy." Drugs Aging 27.2010;(12):1019- 1028.
- Comparative In-Vitro Evaluation of Marketed Paracetamol Tablets
Authors
1 Sultan–Ul–Uloom College of Pharmacy, Road No.3, Banjarahills, Hyderabad- 500034, (A.P.), IN
2 Sultan–Ul–Uloom College of Pharmacy, Road No.3, Banjarahills, Hyderabad-500034, (A.P.), IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 1, No 2 (2009), Pagination: 100-102Abstract
The aim of the present study is to investigate the physicochemical equivalence of five brands of tablets containing paracetamol purchased from different retail pharmacy outlets in Hyderabad, Andhrapradesh, India. The tablets were evaluated for uniformity of weight, friability, hardness, thickness, disintegration, dissolution and assay. All the five brands of the tablets passed the Indian Pharmacopoeia (IP) standards for all in vitro evaluation tests. There was no significant difference in the amount of paracetamol released from the different brands (P>0.05). These results indicate that the tablets of paracetamol purchased from retail outlets in Hyderabad are manufactured and marketed from WHO GMP certified Indian companies. Further work is recommended on bioequivalence of these tablets.Keywords
Paracetamol, Tablets, Evaluation, Marketed.
- Development of Nevirapine Tablets by Direct Compression Method Using Solid Dispersion Technique
Authors
1 Sultan–ul–Uloom College of Pharmacy, Road No: 3, Banjara Hills, Hyderabad – 500034, Telangana State, IN
2 Bojjam Narasimhulu Pharmacy College for Women, Saidabad, Hyderabad – 500059, Telangana State, IN
Source
Journal of Pharmaceutical Research, Vol 16, No 1 (2017), Pagination: 72-79Abstract
Purpose: The aim of the research is to develop Nevirapine tablets by direct compression method by improving solubility using solid dispersion technique.
Methodology: Nevirapine is anti-viral drug, which is used in the prevention and treatment of HIV infections. It belongs to class II drug in Bio-Pharmaceutical Classification System i.e. low solubility and high permeability. It has a biological half-life of 45 hours. One of the major problems with this drug is its low solubility in biological fluids, which results into poor bioavailability after oral administration. Here, solid dispersions of Nevirapine are prepared with different carriers such as Plasdone S-630 and Soluplus in order to increase its solubility and dissolution rate. By increasing the solubility of Nevirapine, its bioavailability can be increased. Pre-formulation studies regarding the drug-carrier interaction was carried out by fourier transform infrared spectroscopy and differential scanning calorimetry. Nevirapine solid dispersions were evaluated for solubility, drug content estimation and in vitro dissolution studies. Powder blend was evaluated for bulk density, tapped density, Carr's index, Hausner's ratio and angle of repose.
Findings: The dissolution pattern of the Nevirapine from all the standard dispersions followed predominantly first order kinetics. The study reflects the vital role of polymers as a novel approach to improve the solubility of nevirapine, which could minimize the variable dissolution rate with increase in bioavailability. With the studies conducted, the percentage drug release of Nevirapine was increased by melting method with Nevirapine: Plasdone S630 in the ratio of 1:2.
Practical implications: Nevirapine is a suitable drug to formulate into tablet by using the above mentioned carriers and may provide a better therapeutic profile than that of conventional dosage form.
Keywords
Nevirapine, PlasdoneS630, Solid Dispersion Technique, Soluplus.Full Text
References
- Patel SS, Benfield P. New drug profile: nevirapine. Clinical Immunotherapeutics. 1996; 6(4): 307–317.
- Amidon GL, Lennernas H, Shah VP, Crison JR. Theoretical basis for a biopharmaceutical classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995; 12(3): 413-420.
- Brahmankar DM, Sunil BJ.Biopharmaceuticsand Pharmacokinetics,A Treatise. 1st ed. Delhi: Vallabh Prakasan; 2005; 27:5-6.
- James S, James CB. Encyclopedia of Pharmaceutical Technology. 2nd ed. 1; 8.
- Chiou WL, Riegelman SJ. Pharmaceutical applications of solid dispersion systems. JPharm Sci. 1971; 60(9): 1281-1302.
- Mamatha T, Taha Minhaj F, Anitha N. Solid Dispersion as an Approach for Dissolution Enhancement of Poorly Water Soluble Drug Ritonavir. Int J Pharm Tech Res. 2016; 9(8): 154-165.
- Raymond CR, Paul JS, Paul JW. Handbookof Pharmaceutical Excipients.4th ed. London: The pharmaceutical press; 2003.
- Dasari A, Velmurugan S. Formulation and Evaluation of NevirapineMucoadhesiveMicrospheres. Int J Pharm Pharm Sci. 2015; 7(6): 342-348.
- Praveen Kumar D, Vandana A. Solid Dispersions: A Review. Journal of Pharmaceutical and Scientific Innovation. 2012; 1(3): 27- 34.
- United States Pharmacopoeia, 32 Edition. United States Pharmacopieal Convention. Inc. Rockville, Md,; 2010; 1.
- Patel SS, Patel Ms, Patel NM. Flowability and packability testing of directly compressible excipients. The Indian Pharmacist. 2008; 65-9.
- Yunxia Bi, Sunada H, Yonezaywa Y, Danjo K, Otsuka A. Preparation and evaluation of compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996; 44(11): 2121-7.
- Mamatha T, Zubair Md, Sarah Nasreen N, Ahmeduddin Md. Formulation and Evaluation of Oro dispersible Tablets of Fosinopril Sodium. Dhaka Univ. J. Pharm. Sci. 2015; 14(1): 11-16.
- Yunxia Bi, Sunada H, Yonezaywa Y, Danjo K. Evaluation of rapidly disintegrating tablets by direct compression method. Drug Dev Ind Pharm. 1999; 25(5): 571-81.
- Brijesh SD, Avani EA, Madhabai MP. Gastro retentive drug delivery system of ranitidine HCl: Formulation and in vitro evaluation. AAPS Pharm Sci Tech. 2004; 5(2).